News

Find News

Filter articles

Showing 1 to 10 of 3302 results

Patent litigation: a global perspective

UK11-05-2021Alex Baldwin

Patent protection is a global affair, so if you find yourself embroiled in litigation, it helps to know what benefits and challenges different jurisdictions can offer.

Mylan fails to void MSD diabetes treatment patent at PTAB

US11-05-2021Muireann Bolger

MSD, known as Merck in the US and Canada, has prevailed against a bid by Mylan Pharmaceuticals and other generic drug makers to invalidate a diabetes treatment patent.

Brazil rules 10-year patent term ‘unconstitutional’

Brazil11-05-2021Alex Baldwin

Brazil’s Supreme Court has ruled that the country’s ten-year patent term is unconstitutional.

WIPO unveils course on genetic resources in the life sciences

International06-05-2021Muireann Bolger

The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.

Sanofi-Aventis gets $17.2m in fees from failed Amphastar suit

US06-05-2021Alex Baldwin

Sanofi-Aventis has been awarded $17.2 million in attorney fees, legal expenses and interest in a district court ruling on a failed suit levied by Amphastar Pharmaceuticals.

Conformis launches implant lawsuit against J&J subsidiary

US04-05-2021Alex Baldwin

US medtech company Conformis has filed a lawsuit against J&J Medical Devices-owned DePuy Synthes, alleging that it infringed on its custom implant and surgery software patents.

Novartis withdraws bid to block US Regeneron imports

US04-05-2021Muireann Bolger

Pharmaceutical company Novartis has abandoned its attempt to halt US imports of Regeneron’s Eylea pre-filled syringes amid concerns that such a ban could hinder public access to essential treatments.

Fed Circ. agrees Bio-Rad infringed 10x patents

US04-05-2021Alex Baldwin

The US Court of Appeals for the Federal Circuit has affirmed a US International Trade Commission (ITC) decision that ruled Bio-Rad Laboratories had infringed three 10x Genomics patents.

GSK claims Amgen v Sanofi decision “threatens” innovation

US29-04-2021Alex Baldwin

GlaxoSmithKline has submitted an amicus brief to the Court of Appeals for the Federal Circuit claiming that the ruling on Amgen v Sanofi could “threaten incentives to invest in future discoveries.”

Dr Reddy’s hits Amarin with antitrust suit over Vascepa

US29-04-2021Muireann Bolger

Amarin delayed the market entry of generic versions of the cardiovascular drug Vascepa by using supply agreements to halt competitors from accessing the drug’s active pharmaceutical ingredient, according to a new antitrust lawsuit.

Showing 1 to 10 of 3302 results

LSIPR